SKI Market

Indian Indices

Sensex

83,085.40 -228.53
( -0.27%)

Global Indices

Nasdaq

48,934.28 -588.03
(-1.19%)

Dow Jones

6,820.12 -83.60
(-1.21%)

Hang Seng

54,176.23 358.19
(0.67%)

Nikkei 225

10,300.09 -102.25
(-0.98%)

Forex

USD-INR

90.39 0.07
(0.07%)

EUR-INR

106.79 0.14
(0.13%)

GBP-INR

123.73 0.13
(0.10%)

JPY-INR

0.58 0.00
(-0.49%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Marksans Pharma consolidated net profit rises 1.58% in the September 2025 quarter

Nov 14,2025

Net profit of Marksans Pharma rose 1.58% to Rs 98.25 crore in the quarter ended September 2025 as against Rs 96.72 crore during the previous quarter ended September 2024. Sales rose 12.23% to Rs 720.41 crore in the quarter ended September 2025 as against Rs 641.92 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	720.41	641.92	12
OPM %	20.06	22.87	-
PBDT	160.25	144.11	11
PBT	133.33	124.60	7
NP	98.25	96.72	2

83,085.40 -228.53 ( -0.27%)

48,934.28 -588.03 (-1.19%)

6,820.12 -83.60 (-1.21%)

54,176.23 358.19 (0.67%)

10,300.09 -102.25 (-0.98%)

90.39 0.07 (0.07%)

106.79 0.14 (0.13%)

123.73 0.13 (0.10%)

0.58 0.00 (-0.49%)